logo
#

Latest news with #WADC

Australian tennis player Thomas Fancutt hit with 10-month doping ban
Australian tennis player Thomas Fancutt hit with 10-month doping ban

7NEWS

time19 hours ago

  • Sport
  • 7NEWS

Australian tennis player Thomas Fancutt hit with 10-month doping ban

Australian doubles player Thomas Fancutt has issued a statement after accepting a 10-month doping ban from the International Tennis Integrity Agency (ITIA). The ITIA sent Fancutt 'a notice of a potential anti-doping rule violation' on March 7 this year, and he immediately requested to enter a voluntary provisional suspension as the investigation took place. Now, after all the evidence has been gathered, Fancutt has admitted to the breach and been suspended. The suspension follows an 18-month doping ban to Aussie tennis star Max Purcell (who was ranked as high as No.8 in doubles) just a handful of months ago. Fancutt said he 'unknowingly violated an anti-doping rule' when taking an intravenous vitamin infusion. Purcell's ban also followed an IV infusion of vitamins. 'The ITIA sent the player (Fancutt) a notice of a potential anti-doping rule violation (ADRV) on 7 March 2025,' the ITIA said. 'Following a full investigation by the ITIA ... Fancutt admitted to the breach, and the ITIA accepted that the breach was not intentional. 'The ITIA considered relevant precedents across all WADC-compliant sports, in addition to the player's early admission and full co-operation.' Fancutt accepted his intravenous infusion in December 2024 was over the accepted limit — the limit under the World Anti-Doping Code (WADC) and TADP is 100ml in a 12-hour period. Fancutt — who reached a career-high world doubles ranking of 107 in December 2024 — is expected return in January next year (the ban ends on January 18) and could play in the Australian Open. In the meantime, he will however forfeit results and prize money from the date of his first anti-doping rule violation on December 3, 2024, to the first subsequent negative doping control sample, which was provided on January 16, 2025. Fancutt said he was devastated but stressed it was an accident. 'To the International tennis community, at the end of my 2024 season, I unknowingly violated an anti-doping rule by receiving a 500ml IV infusion to combat severe fatigue,' he said on social media. 'The contents of the infusion were solely Vitamin B, Vitamin C and magnesium. The IV infusion amount however exceeded 100mls which regardless of its content is prohibited under anti-doping regulations, something I was completely unaware of at the time. 'I have always taken great pride in being a clean athlete, and this situation has been devastating for me. While I am deeply disappointed by the suspension, I remain fully committed to the sport and look forward to returning to competition as soon as this matter is resolved. 'During the time, I am fully cooperating with the ITIA and am incredibly grateful for the support of the PTPA and everyone standing by me. I appreciate your understanding and support, and I can't wait to be back on tour.'

Australia tennis player receives 10-month doping suspension, ITIA accepts explanation
Australia tennis player receives 10-month doping suspension, ITIA accepts explanation

Hindustan Times

timea day ago

  • Sport
  • Hindustan Times

Australia tennis player receives 10-month doping suspension, ITIA accepts explanation

Aussie tennis ace Thomas Fancutt has accepted a ten-month suspension for a doping violation. The suspension was given by the International Tennis Integrity Agency (ITIA), and the 30-year-old was also placed under voluntary provisional suspension in March. During the investigation, the player accepted the doping breach, and the ITIA also accepted his explanation.(HT_PRINT) During the investigation, the player accepted the doping breach, and the ITIA also accepted his explanation that it was accidental. His suspension will last till January 18, 2026, as the time in his provisional suspension will also be counted. The ITIA in its statement said, '30-year-old Fancutt, who reached a career-high world doubles ranking of 107 in December 2024, admitted to breaching Article 2.2 of the TADP (use of a Prohibited Method) by receiving an intravenous infusion over the accepted limit on 3 December 2024. The limit under the World Anti-Doping Code (WADC) and TADP is 100mL in a 12-hour period.' The statement further added, 'Time served under the voluntary provisional suspension is credited against the period of ineligibility. As such, Fancutt's suspension will end on 18 January 2026. The player will also forfeit results and prize money from the date of their first ADRV (3 December 2024) to their first subsequent negative doping control sample, which was provided on 16 January 2025. During the period of ineligibility, Fancutt is prohibited from playing in, coaching at, or attending any tennis event authorised or sanctioned by the members of the ITIA (ATP, ITF, WTA, Tennis Australia, Fédération Française de Tennis, Wimbledon and USTA) or any national association.' Fancutt has a career-high singles ranking of 382, and currently, he is 723rd in the ATP leaderboard. In doubles, he has a career-high ranking of 107.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store